| Product Name | NebuSelect™ Recombinant Human IL-13, hFc-tag |
|---|---|
| Catalog Number | NBL-242507 |
| Alias/Synonyms | IL-13; IL13; IL-13; interleukin 13; NC30; P600; ALRH; BHR1; MGC116786; MGC116788; MGC116789 |
| Appearance | see COA |
| Molecule Weight | |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | AAK53823 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242507-100ug | 100ug | Inquire | Inquire | |
| NBL-242507-1mg | 1mg | Inquire | Inquire | |
| NBL-242507-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human IL-13, hFc-tag
Catalog#:
NBL-242507
Description:
NebuSelect™ Recombinant Human IL-13, hFc-tag(Cat#NBL-242507) is expressed in HEK293 with hFc tag at the N-Terminus.It contains Gly21-Asn132.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 39.6 kDa. Due to glycosylation, the protein migrates to 50-70 kDa based on Bis-Tris PAGE result.
Target Name:
IL-13; IL13; IL-13; interleukin 13; NC30; P600; ALRH; BHR1; MGC116786; MGC116788; MGC116789
Target Information:
Interleukin-13 (IL-13) is a monomeric 17 kDa immunoregulatory cytokine that plays a key role in the pathogenesis of allergy, cancer, and tissue fibrosis. It is secreted by several helper T cell subsets, NK cells, mast cells, eosinophils, basophils, and visceral smooth muscle cells. Inhibits inflammatory cytokine production. Synergizes with IL2 in regulating interferon-gamma synthesis. May be critical in regulating inflammatory and immune responses. Positively regulates IL31RA expression in macrophages (By similarity).
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.